MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku,
Tokyo; CEO: Koji Eguchi; listed on Nasdaq, NASDAQ: MRM; hereinafter
“MEDIROM”) announces that its subsidiary MEDIROM MOTHER Labs Inc.
(Headquarters: Minato-ku, Tokyo; CEO: Yoshio Uekusa; hereinafter
“MOTHER Labs”), has formed a capital and business alliance with
NFES Technologies Inc. (Headquarters: Matsue City, Shimane
Prefecture; CEO: Keita Adachi; hereinafter “NFES Group”), a
subsidiary of NFES Inc. (Headquarters: Matsue City, Shimane
Prefecture; CEO: Keita Adachi).
As part of this alliance, NFES Group has agreed to participate
as the lead investor in MOTHER Labs’ Series A financing round,
which values MOTHER Labs at 9 billion yen on a pre-money basis. The
Series A shares will be issued to NFES Group as a third-party
allotment.
◾️Background of the Capital and Business
AllianceThe NFES Group is committed to creating a world
where individuals can passionately pursue what they love. They
resonate with MOTHER Labs’ dedication to global challenges as a
Japanese company and the concept behind the MOTHER Bracelet, a
recharge-free smart tracker designed to monitor people’s health.
This shared vision led to the capital and business alliance, with
the aim of collaborating with MOTHER Labs to promote the MOTHER
Bracelet and support the health of people worldwide.
◾️Future InitiativesWe have concluded a
distributorship agreement for MOTHER Bracelet, the recharge-free
smart tracker developed by the MEDIROM group, and MOTHER Gateway,
MEDIROM’s telecommunication device which exclusively enables data
generated by MOTHER Bracelet to be sent to our proprietarily
developed remote monitoring system, and will introduce these
products to companies in the nursing care, transportation, and
manufacturing industries and promote their introduction through
collaborations with financial institutions and sales partners
allied with NFES Group.
In addition, MOTHER Labs will also collaborate with
Hyakkaten.com (a regional department store e-commerce mall operated
by NFES Group) to conduct general sales through department stores
and e-commerce sites nationwide.
With NFES Group participating as the lead investor in this
Series A round, we anticipate attracting additional investors,
allowing us to secure the necessary funds for MOTHER Labs’ business
expansion and facilitating the company’s further business
development.
◾️Sales StructureThe NFES Group has established
a new company, NFES Technologies Inc., specializing in sales of
MOTHER Bracelet and plans to expand sales both domestically and
internationally as the designated main distributor of MOTHER
Bracelet products.
Forward-Looking Statements Regarding MEDIROM and MOTHER
Labs
Certain statements in this press release are forward-looking
statements for purposes of the safe harbor provisions under the
U.S. Private Securities Litigation Reform Act of 1995.
Forward-looking statements may include estimates or expectations
about MEDIROM’s possible or assumed operational results, financial
condition, business strategies and plans, market opportunities,
competitive position, industry environment, and potential growth
opportunities. In some cases, forward-looking statements can be
identified by terms such as “may,” “will,” “should,” “design,”
“target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,”
“anticipate,” “estimate,” “believe,” “continue,” “predict,”
“project,” “potential,” “goal,” or other words that convey the
uncertainty of future events or outcomes. These statements relate
to future events or to MEDIROM’s future financial performance, and
involve known and unknown risks, uncertainties and other factors
that may cause MEDIROM’s actual results, levels of activity,
performance, or achievements to be different from any future
results, levels of activity, performance or achievements expressed
or implied by these forward-looking statements. You should not
place undue reliance on forward-looking statements because they
involve known and unknown risks, uncertainties and other factors
which are, in some cases, beyond MEDIROM’s control and which could,
and likely will, affect actual results, levels of activity,
performance or achievements. Any forward-looking statement reflects
MEDIROM’s current views with respect to future events and is
subject to these and other risks, uncertainties and assumptions
relating to MEDIROM’s operations, results of operations, growth
strategy and liquidity. Some of the factors that could cause actual
results to differ materially from those expressed or implied by the
forward-looking statements in this press release include:
- MEDIROM’s ability to achieve its development goals for its
business and execute and evolve its growth strategies, priorities
and initiatives;
- MEDIROM’s and NFES Group’s ability to collaborate in the
anticipated manner and on the expected terms;
- MOTHER Labs’ ability to secure additional investors in its
Series A financing round on acceptable terms, or at all;
- changes in Japanese and global economic conditions and
financial markets, including their effects on MEDIROM’s expansion
in Japan and certain overseas markets;
- MEDIROM’s ability to achieve and sustain profitability in its
Digital Preventative Healthcare
Segment;
- the fluctuation of foreign exchange rates, which affects
MEDIROM’s expenses and liabilities payable in foreign
currencies;
- MEDIROM’s ability to maintain and enhance the value of its
brands and to enforce and maintain its trademarks and protect its
other intellectual property;
- MEDIROM’s ability to raise additional capital on acceptable
terms or at all;
- MEDIROM’s level of indebtedness and potential restrictions on
MEDIROM under MEDIROM’s debt instruments;
- changes in consumer preferences and MEDIROM’s competitive
environment;
- MEDIROM’s ability to respond to natural disasters, such as
earthquakes and tsunamis, and to global pandemics, such as
COVID-19; and
- the regulatory environment in which MEDIROM operates.
More information on these risks and other potential factors that
could affect MEDIROM’s business, reputation, results of operations,
financial condition, and stock price is included in MEDIROM’s
filings with the Securities and Exchange Commission (the “SEC”),
including in the “Risk Factors” and “Operating and Financial Review
and Prospects” sections of MEDIROM’s most recently filed periodic
report on Form 20-F and subsequent filings, which are available on
the SEC website at www.sec.gov. MEDIROM assumes no obligation to
update or revise these forward-looking statements for any reason,
or to update the reasons actual results could differ from those
anticipated in these forward-looking statements, even if new
information becomes available in the future.
■MEDIROM MOTHER Labs Inc.
MEDIROM MOTHER Labs Inc., a subsidiary of MEDIROM Healthcare
Technologies Inc., primarily focuses on the health tech sector. The
company’s core activities include the “Specific Health Guidance
Program” offered through the “Lav” health application and
development and sales of the 24/7 recharge-free MOTHER Bracelet
smart tracker. The tracker’s popularity raised a record-breaking
56.1 million yen on the Japanese crowdfunding platform “Makuake”.
By leveraging the features of the recharge-free MOTHER Bracelet,
MOTHER Labs offers customizable health management solutions across
diverse sectors, including caregiving, logistics, manufacturing,
etc.
・Company OverviewCompany Name: MEDIROM MOTHER Labs
Inc.Headquarters: Tradepia Odaiba, 2-3-1 Daiba, Minato-ku,
TokyoRepresentative: Kouji Eguchi, Yoshio UekusaEstablishment: July
2023Business Area: Health Tech Business / Device Business /
Software Services
■About MEDIROM Healthcare Technologies
Inc.・Company OverviewCompany Name: MEDIROM Healthcare
Technologies Inc.Listed Market: NASDAQTicker Symbol: MRM
Headquarters: Tradepia Odaiba, 2-3-1 Daiba, Minato-ku,
TokyoCEO/Founder: Kouji EguchiEstablishment: July 2000URL:
https://medirom.co.jp/en
◾️About NFES Technologies Inc.
NFES Technologies Inc. is a health tech company established as a
subsidiary of NFES Corporation, which develops creative business.
The company will develop its business centered on sales and system
linkage of the MOTHER Bracelet smart tracker, which requires no
recharging 24 hours a day, 365 days a year, and the MOTHER Gateway
telecommunication device.
Company name: NFES Technologies, Inc.Head Office: Shimane Bank
Head Office Building 11F, 484-19 Asahi-cho, Matsue City, Shimane
PrefectureRepresentative: Keita Adachi, CEOEstablishment: July
2024Business: Health tech businessURL: https://nfes-tech.com
◾️About NFES Inc.
Company name: NFES Inc.Head Office: Shimane Bank Head Office
Bldg. 11F, 484-19 Asahi-cho, Matsue City, Shimane
PrefectureRepresentative: Keita Adachi, CEOEstablishment: May
2022Business description: Creative businessURL:
https://nfes.fun
ContactsInvestor Relations Teamir@medirom.co.jp
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/733fb149-5951-4cd8-8eff-36a9480f8d75
https://www.globenewswire.com/NewsRoom/AttachmentNg/5208a192-b2b6-4eeb-9991-cd0bb357947f
https://www.globenewswire.com/NewsRoom/AttachmentNg/f4ab65e0-2b41-4982-90a1-5d9c19f4e9d5
https://www.globenewswire.com/NewsRoom/AttachmentNg/9e3433cd-4f86-4c26-bdc9-3cd916359712
https://www.globenewswire.com/NewsRoom/AttachmentNg/2fbe48d1-176e-40b4-a927-2652a4a14235
https://www.globenewswire.com/NewsRoom/AttachmentNg/4a44978d-ea5e-40d1-9e7b-0440f39791bb
MEDIROM Healthcare Techn... (NASDAQ:MRM)
過去 株価チャート
から 11 2024 まで 12 2024
MEDIROM Healthcare Techn... (NASDAQ:MRM)
過去 株価チャート
から 12 2023 まで 12 2024